Applied StemCell, Inc. ("ASC"), a biotechnology company with deep expertise and intellectual property in induced pluripotent stem cell (iPSC) technology, and RoosterBio, Inc., a leading supplier of ...

CMS proposes paying 340B-acquired drugs at ASP minus 33.4% starting CY 2027, replacing ASP plus 6%, based on survey findings that acquisition costs are well below ASP. Projected 2027 impact includes ...

Detailed price information for Silver Elephant Mining Corporation (ELEF-T) from The Globe and Mail including charting and trades.

Nyxoah Announces Preliminary Results for the Second Quarter of 2026 Continued U.S. launch momentum drives second quarter global preliminary net ...

The next major Medicare risk for spine and orthopedic practices may not begin with a denied surgical claim. It may begin with the enrollment file. CMS’ July 1 proposed rule is formally a home health ...

T.H.E. Show SoCal 2026 showcased some of the best hi-fi systems, speakers, amplifiers, and audiophile DACs. Jacob Green shares his standout listening impressions from the show's top demos.

CMS plans to cut what Medicare pays hospitals for drugs bought through the 340B program and push site-neutral payment into a new category of outpatient services, two proposals that together would pull ...

Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") issues this press release to amend and restate in ...

Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its ...

The Centers for Medicare & Medicaid Services is proposing to decrease payments to hospitals that purchase drugs under the 340B program to align the rate to reflect what providers pay for the ...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...

The ARTx3 Campus, which comprises The Arts & Science Center for Southeast Arkansas, The ARTSpace on Main and ART WORKS on ...